论文部分内容阅读
目的:探讨疏血通治疗急性脑梗死(acute cerebral infarction,ACI)的临床疗效和它对血液流变学的影响。方法:128例ACI患者随机分为两组,治疗组70例,用疏血通和舒血宁治疗15天,对照组用舒血宁治疗15天,两组常规治疗如调整血压、血糖、颅内压及营养脑细胞等相同。观察两组治疗前后神经功能缺损程度(SSS评分)、血液流变学的变化。结果:治疗组有效率90.0%,对照组81.0%,有统计学差异(P<0.05)。治疗组的SSS评分、血液流变学明显较治疗前改善(P<0.05)。结论:疏血通治疗ACI安全有效。
Objective: To investigate the clinical efficacy of Shuxuetong in the treatment of acute cerebral infarction (ACI) and its effect on hemorheology. Methods: 128 patients with ACI were randomly divided into two groups, the treatment group of 70 cases, with Shuxuetong and Shuxuening 15 days, the control group Shuxuening 15 days, the two conventional treatment such as adjusting blood pressure, blood sugar, The same pressure and nutrition brain cells. The changes of neurological deficit (SSS score) and hemorheology before and after treatment in both groups were observed. Results: The effective rate was 90.0% in the treatment group and 81.0% in the control group, with statistical significance (P <0.05). The SSS score and hemorheology of the treatment group were significantly improved compared with those before treatment (P <0.05). Conclusion: Shuxuetong treatment of ACI safe and effective.